A new type of cancer therapy that uses a common virus to infect and destroy harmful cells is showing big promise in early human trials, say UK scienti

Cancer-killing virus shows promise in patients

submited by
Style Pass
2022-09-23 09:00:05

A new type of cancer therapy that uses a common virus to infect and destroy harmful cells is showing big promise in early human trials, say UK scientists.

Larger and longer studies will be needed, but experts say the injection might ultimately offer a lifeline to more people with advanced cancers.

Krzysztof Wojkowski, a 39-year-old builder from west London, is one of the patients who took part in the ongoing phase one safety trial, run by the Institute of Cancer Research at the Royal Marsden NHS Foundation Trust.

He was diagnosed in 2017 with cancer of the salivary glands, near the mouth. Despite surgery and other treatments at the time, his cancer continued to grow.

"I was told there was no options left for me and I was receiving end-of-life care. It was devastating, so it was incredible to be given the chance to join the trial."

A short course of the virus therapy - which is a specially modified version of the herpes virus which normally causes cold sores - appears to have cleared his cancer.

Leave a Comment